Get started
Author

Stefan A. Steurer

Observed names: S STEURER, S Steuerer, S Steurer, S. Steurer, S., Steurer, STEFAN STEURER, Stefan A Steurer, Stefan Steurer, Steurer Stefan, Steurer, Stefan
Observed institutions: University of Vienna, Universität Hamburg, University of Basel, Medical University of Graz, Vienna General Hospital, Comprehensive Cancer Center Vienna, Wilhelminen Hospital, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg, Marienkrankenhaus Hamburg, German Center for Lung Research, Pantarhei Bioscience (Netherlands), Otto Wagner Hospital, Novartis (Austria), Medical University of Vienna
ORCID: 0000-0002-7199-3615
Observed ORCIDs: 0000-0002-7199-3615, 0000-0003-3313-0453
OpenAlex ID: A5049914905
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
2020 · Dominic Wichmann, Jan-Peter Sperhake, et al. · Annals of Internal Medicine · 2,274
Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany
2020 · Carolin Edler, Ann Sophie Schröder, et al. · International Journal of Legal Medicine · 425
PDF
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
2013 · Joachim Weischenfeldt, Ronald Simon, et al. · Cancer Cell · 322
PDF
Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) Increases Nerve-sparing Frequency and Reduces Positive Surgical Margins in Open and Robot-assisted Laparoscopic Radical Prostatectomy: Experience After 11 069 Consecutive Patients
2012 · Thorsten Schlomm, Pierre Tennstedt, et al. · European Urology · 285
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
2015 · Guido Sauter, Stefan Steurer, et al. · European Urology · 277
Clonal expansion and activation of tissue-resident memory-like T H 17 cells expressing GM-CSF in the lungs of patients with severe COVID-19
2021 · Yu Zhao, Christoph Kilian, et al. · Science Immunology · 161
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
2013 · Martina Kluth, Jana Hesse, et al. · Modern Pathology · 138
PDF
A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
2016 · Penelope Pelczar, Mario Witkowski, et al. · Science · 136
Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells
2003 · Gerald W. Prager, Johannes M. Breuss, et al. · Blood · 130
PDF
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion‐positive prostate cancers
2013 · Antje Krohn, Annemarie Seidel, et al. · The Journal of Pathology · 125
Multi-scale fully convolutional neural networks for histopathology image segmentation: From nuclear aberrations to the global tissue architecture
2021 · Rüdiger Schmitz, Frederic Madesta, et al. · Medical Image Analysis · 115
PDF
Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors
2022 · David Dum, Noushin Taherpour, et al. · Pathobiology · 109
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
2021 · Sören Weidemann, Pauline Gagelmann, et al. · Biomedicines · 108
PDF
Activation of Nuclear Factor-κB Significantly Contributes to Lumen Loss in a Rabbit Iliac Artery Balloon Angioplasty Model
2002 · J.M. Breuss, M. Cejna, et al. · Circulation · 90
Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer
2018 · Waldemar Wilczak, Corinna Wittmer, et al. · European Urology · 82
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors
2021 · Stefan Steurer, Claudia Riemann, et al. · Biomarker Research · 80
PDF
Vascular Endothelial Growth Factor Receptor-2–Induced Initial Endothelial Cell Migration Depends on the Presence of the Urokinase Receptor
2004 · Gerald W. Prager, Johannes M. Breuss, et al. · Circulation Research · 80
Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer
2014 · Antje Krohn, Fabian Freudenthaler, et al. · Modern Pathology · 78
Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer
2019 · Niclas C. Blessin, Ronald Simon, et al. · Disease Markers · 76
PDF
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers
2022 · David Dum, Anne Menz, et al. · Experimental and Molecular Pathology · 75
IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues
2017 · Christoph Burdelski, Nilofar Jakani-Karimi, et al. · Oncology Reports · 74
PDF
Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors
2021 · Anne Menz, Timo Weitbrecht, et al. · Molecular Medicine · 72
PDF
Molecular control of endurance training adaptation in male mouse skeletal muscle
2023 · Regula Furrer, Barbara Heim, et al. · Nature Metabolism · 71
PDF
E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors
2021 · Eike Burandt, Felix Lübbersmeyer, et al. · Biomarker Research · 70
PDF
High mitochondria content is associated with prostate cancer disease progression
2013 · Katharina Grupp, Karolina Jedrzejewska, et al. · Molecular Cancer · 69
PDF
Works count: 455
Citation count: 9,835
H-index: 43
I10-index: 167
Year
Topic
Type